Ask AI
ProCE Banner Activity

Reimagining Treatment Pathways in Schizophrenia: Challenging Old Models and Creating New Solutions

Slideset

Emerging treatment approaches for schizophrenia are expanding beyond traditional dopamine-targeting antipsychotics. These downloadable slides from Psychopharmacology Update 2026 examine unmet treatment needs, muscarinic receptor pharmacology, and the clinical evidence for approved and investigational muscarinic agents. Explore differences in mechanisms of action, efficacy, tolerability, and practical considerations for integrating novel therapies into individualized schizophrenia management.

Released: November 18, 2026

Continue Activity

Share

Provided by

Provided by Clinical Care Options, LLC dba Decera Clinical Education

ProCE Banner

Supporters

Supported by an educational grant from Bristol-Myers Squibb.

Bristol Myers Squibb

Target Audience

This activity is intended for healthcare professionals caring for patients with schizophrenia including psychiatrists, physicians, nurse practitioners, physician associates, registered nurses, pharmacists, social workers, and psychologists.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Identify unmet needs in the management of schizophrenia with traditional antidopaminergic antipsychotics and the potential for safety and efficacy improvements with novel agents

  • Apply an understanding of the mechanisms of action and pharmacokinetic characteristics of new and emerging schizophrenia treatments in counseling patients on dosing, administration, and food requirements

  • Integrate muscarinic pharmacology into advanced clinical decision-making and treatment planning for schizophrenia

Additional Disclosures

Generative artificial intelligence (AI) tools were used for revising or refining educational content. All AI-assisted content underwent human review, editing, and validation by qualified faculty and accredited education staff to ensure scientific accuracy, balance, and compliance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education.